Sentinel Lymph Node
Conditions
Brief summary
The purpose of this study is to analyze the average direct costs of each of these techniques, represented by the costs directly linked to the management of breast cancer, to the surgical intervention and to the techniques evaluated (Indocyanine Green and isotopes) which are: consultations, hospitalizations, resources consumed during the surgical intervention, as well as the time of the patients, transport...
Detailed description
The main objective is to evaluate the overall cost at 1 month of the sentinel lymph node detection technique using Indocyanine Green compared to the technique using isotopes in patients with breast cancer, from the point of view of health insurance and the hospital. The chosen time horizon is up to 1 month post-intervention. The choice of this time horizon corresponds to the usual duration of follow-up for patients who have benefited from one of the sentinel lymph node detection techniques, in order to collect the main post-surgical complications. This is a multicenter, prospective, observational, non-randomized study, aimed at comparing the overall cost of two sentinel lymph node detection techniques (Indocyanine Green and isotope) from a dual perspective (health insurance and hospital).
Interventions
OTHERSentinel node detection technique
Patients cared for by a surgeon for histologically proven breast cancer and for whom an indication for detection of the sentinel lymph node is posed.
Sponsors
GCS Ramsay Santé pour l'Enseignement et la Recherche
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patient aged 18 or over, having given her oral non-objection ; * Patient with histologically proven breast cancer ; * Patient eligible for the sentinel lymph node technique by Indocyanine Green or isotopes.
Exclusion criteria
* Patient who has expressed her opposition to the use of her medical data ; * Patient under legal protection, guardianship or curatorship ; * Pregnant patient ; * Patient not affiliated to a social security scheme.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Average direct costs of the two techniques assessed (Indocyanine Green and isotopes) | 1 month | To evaluate the overall cost at 1 month of the sentinel lymph node detection technique using Indocyanine Green compared to the technique using isotopes in patients with breast cancer, from the point of view of the health insurance and the hospital. |
Countries
France
Outcome results
None listed